Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Kala Pharmaceuticals, Inc. (KALA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
Visitors trend2W10W9M
0.3239-0.0066 (-2.00%)
At close: 04:00PM EDT
0.3290 +0.01 (+1.57%)
After hours: 04:07PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 8/17/2022
Current
6/30/20223/31/202212/31/20219/30/20216/30/2021
Market Cap (intraday)
24.33M21.80M100.18M79.26M170.52M343.28M
Enterprise Value
59.61M32.36M88.23M61.79M127.98M289.33M
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
2.792.198.016.4614.5435.68
Price/Book (mrq)
N/AN/A5.961.292.023.13
Enterprise Value/Revenue
7.1015.4164.3133.2941.7394.83
Enterprise Value/EBITDA
-0.47-1.26-2.87-1.36-4.96-8.47

Trading Information

Stock Price History

Beta (5Y Monthly) 1.03
52-Week Change 3-88.01%
S&P500 52-Week Change 3-2.99%
52 Week High 33.6100
52 Week Low 30.2810
50-Day Moving Average 30.3429
200-Day Moving Average 30.9439

Share Statistics

Avg Vol (3 month) 31.88M
Avg Vol (10 day) 31.37M
Shares Outstanding 573.21M
Implied Shares Outstanding 6N/A
Float 861.12M
% Held by Insiders 17.46%
% Held by Institutions 119.40%
Shares Short (Jul 28, 2022) 41.82M
Short Ratio (Jul 28, 2022) 41.61
Short % of Float (Jul 28, 2022) 43.58%
Short % of Shares Outstanding (Jul 28, 2022) 42.51%
Shares Short (prior month Jun 29, 2022) 42.16M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,307.27%

Management Effectiveness

Return on Assets (ttm)-45.66%
Return on Equity (ttm)-518.81%

Income Statement

Revenue (ttm)8.39M
Revenue Per Share (ttm)0.12
Quarterly Revenue Growth (yoy)-31.20%
Gross Profit (ttm)7.14M
EBITDA -108.97M
Net Income Avi to Common (ttm)-136.75M
Diluted EPS (ttm)-2.1370
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)44.57M
Total Cash Per Share (mrq)0.61
Total Debt (mrq)79.85M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.54
Book Value Per Share (mrq)-0.43

Cash Flow Statement

Operating Cash Flow (ttm)-103.5M
Levered Free Cash Flow (ttm)-68.63M
Advertisement
Advertisement